Clinical study of Descemet membrane endothelial keratoplasty (DMEK) for patients with bullous keratopathy

Clinical study of Descemet membrane endothelial keratoplasty (DMEK) for patients with bullous keratopathy - Clinical study of Descemet membrane endothelial keratoplasty (DMEK) for patients with bullous keratopathy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014242

Enrollment

Registered

2014-06-12

Start date

2014-06-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bullous keratopathy

Interventions

Descemet membrane endothelial keratoplasty

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Bullous keratopathy patients who are indicated for Endothelial Keratoplasty in Osaka University Hospital 2)Aged 20 years old and over 3)Written informed consent

Exclusion criteria

Exclusion criteria: 1)Bullous keratopathy patients who are not indicated for Endothelial Keratoplasty 2)Those who have been decided not appropriate for enrollment by the principal investigator. 3)Patients of less than 6 months follow-up period.

Design outcomes

Primary

Measure	Time frame
corneal thickness after surgery	—

Secondary

Measure	Time frame
visual acuity, survival of the graft, corneal endothelial cell density, success in DMEK graft preparation, success in the graft transplantation, complication	—

Countries

Japan

Contacts

Public ContactTakeshi Soma

Osaka University Graduate School of Medicine Department of Ophthalmology

soma@ophthal.med.osaka-u.ac.jp06-6879-3456

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026